デフォルト表紙
市場調査レポート
商品コード
1587161

血栓管理デバイス市場:製品別、エンドユーザー別-2025-2030年の世界予測

Clot Management Devices Market by Product (Catheter-Directed Thrombolysis devices, Embolectomy Balloon Catheters, Inferior Vena Cava Filters), End-User (Diagnostic Centers, Hospitals) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 182 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血栓管理デバイス市場:製品別、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血栓管理デバイス市場は、2023年に19億5,000万米ドルと評価され、2024年には20億6,000万米ドルに達すると予測され、CAGR 5.73%で成長し、2030年には28億8,000万米ドルに達すると予測されています。

血栓管理デバイスは、深部静脈血栓症、肺塞栓症、脳卒中などの血栓性疾患の治療と予防に重点を置く医療機器業界では欠かせない存在です。これらのデバイスは、カテーテルや血栓除去デバイスから機械的血栓除去システムまで多岐にわたり、主に病院、診療所、外来手術センターで使用されています。座りっぱなしのライフスタイルの普及と高齢化が相まって血栓性障害が増加し、効果的な血栓管理ソリューションの必要性が高まっています。この急増は、低侵襲で治療効果を高める次世代血栓除去装置の開発などの技術的進歩と相まって、市場の主要な成長要因となっています。しかし、規制当局の厳しい承認や先端機器に関連する高コストといった要因が大きな課題となっています。新たなビジネスチャンスは、血栓管理システムと統合可能な遠隔医療および遠隔モニタリング・ソリューションの拡大にあり、アクセシビリティと患者管理を強化します。さらに、個別化医療への注目の高まりは、転帰を改善する患者専用機器の革新に道を開く可能性があります。企業は、研究開発に投資して、進化するヘルスケア標準に適合する、軽快で費用対効果の高い高性能機器を開発することで、こうした機会を活用することができます。ヘルスケアプロバイダーや技術系企業との積極的な提携や協力関係も、市場への浸透と技術革新の共有を促進します。とはいえ、変動する償還政策を乗り切り、ヘルスケア・インフラの地域格差に適応することは、依然として継続的な課題です。市場関係者は、規制の変更に遅れないことを優先し、新技術のより良い導入のためにヘルスケア専門家のトレーニングに投資すべきです。AIを活用した診断ツールや血栓回収用の生分解性材料といった革新的な分野に注力することで、企業は満たされていないニーズに対応し、より幅広いセグメントを獲得することができます。市場の競争は激しく、持続的な成長のためには戦略的な機敏さと強固な調査戦略が必要です。

主な市場の統計
基準年[2023] 19億5,000万米ドル
予測年[2024] 20億6,000万米ドル
予測年[2030] 28億8,000万米ドル
CAGR(%) 5.73%

市場力学:急速に進化する血栓管理デバイス市場の主要市場インサイトを公開

血栓管理デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 冠動脈性心疾患や末梢動脈性疾患などの重篤な疾患の増加
    • 疾患発症リスクが高い高齢者人口の増加
    • 効果的な血栓除去/塞栓除去装置の需要
  • 市場抑制要因
    • いくつかの経済地域における従来の方法
  • 市場機会
    • ヘルスケア施設を開発するための投資の増加
    • 経皮的デバイスの受け入れ拡大
  • 市場の課題
    • 熟練医師の不足と償還不足

ポーターの5つの力:血栓管理デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:血栓管理デバイス市場における外部からの影響の把握

外部マクロ環境要因は、血栓管理デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血栓管理デバイス市場における競合情勢の把握

血栓管理デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血栓管理デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血栓管理デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血栓管理デバイス市場における成功への道筋を描く

血栓管理デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 冠状動脈疾患や末梢動脈疾患などの重篤な疾患の増加
      • 高齢者人口の増加は疾病発症リスクの上昇に近づく
      • 効果的な血栓除去・塞栓除去装置の需要
    • 抑制要因
      • いくつかの経済における従来の方法の実践
    • 機会
      • ヘルスケア施設開発への投資増加
      • 経皮的デバイスの受容度の向上
    • 課題
      • 熟練した医師の不足と医療費の払い戻し不足
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 血栓管理デバイス市場:製品別

  • カテーテル誘導血栓溶解装置
  • 塞栓除去バルーンカテーテル
  • 下大静脈フィルター
  • 神経血管塞栓除去デバイス
  • 経皮血栓除去装置

第7章 血栓管理デバイス市場:エンドユーザー別

  • 診断センター
  • 病院

第8章 南北アメリカの血栓管理デバイス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の血栓管理デバイス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの血栓管理デバイス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Acandis GmbH
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • LeMaitre Vascular, Inc.
  • Medela AG
  • Medtronic PLC
  • Merck KGaA
  • Merit Medical Systems, Inc
  • Penumbra, Inc
  • Siemens AG
  • Teleflex Incorporated
  • Terumo Corporation
図表

LIST OF FIGURES

  • FIGURE 1. CLOT MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CLOT MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CLOT MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CLOT MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLOT MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLOT MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY CATHETER-DIRECTED THROMBOLYSIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY EMBOLECTOMY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY NEUROVASCULAR EMBOLECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLOT MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM CLOT MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM CLOT MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. CLOT MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. CLOT MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-ED54C46E8702

The Clot Management Devices Market was valued at USD 1.95 billion in 2023, expected to reach USD 2.06 billion in 2024, and is projected to grow at a CAGR of 5.73%, to USD 2.88 billion by 2030.

Clot management devices are essential within the medical device industry, focusing primarily on the treatment and prevention of thrombotic conditions such as deep vein thrombosis, pulmonary embolism, and stroke. These devices range from catheters and thrombectomy devices to mechanical thrombectomy systems, primarily used across hospitals, clinics, and ambulatory surgical centers. The increasing prevalence of sedentary lifestyles, coupled with an aging population, has led to a rise in thrombotic disorders, accentuating the necessity for effective clot management solutions. This surge is a key growth factor for the market, coupled with technological advancements, such as the development of next-generation thrombectomy devices which offer minimally invasive and enhanced treatment efficacy. However, factors such as stringent regulatory approvals and the high costs associated with advanced devices pose significant challenges. Emerging opportunities lie in expanding telemedicine and remote monitoring solutions that can be integrated with clot management systems, enhancing accessibility and patient management. Additionally, the increasing focus on personalized medicine could pave the way for innovations in patient-specific devices that improve outcomes. Businesses can capitalize on these opportunities by investing in research and development to create nimble, cost-effective, and high-performance devices that meet evolving healthcare standards. Active partnerships and collaborations with healthcare providers and technological firms can also facilitate deeper market penetration and innovation sharing. Nevertheless, navigating fluctuating reimbursement policies and adapting to regional disparities in healthcare infrastructure remain ongoing challenges. Market players should prioritize staying abreast of regulatory changes and invest in training healthcare professionals for better adoption of new technologies. By focusing on the areas of innovation like AI-driven diagnostic tools and biodegradable materials for clot retrieval, companies can address unmet needs and capture a broader segment. The market is distinctly competitive, necessitating strategic agility and robust research strategies for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.95 billion
Estimated Year [2024] USD 2.06 billion
Forecast Year [2030] USD 2.88 billion
CAGR (%) 5.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clot Management Devices Market

The Clot Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing critical diseases including coronary heart diseases and peripheral arterial diseases
    • Rising elderly population closer to higher risk to diseases development
    • Demand for effective thrombectomy/embolectomy devices
  • Market Restraints
    • Conventional method practices in several economies
  • Market Opportunities
    • Increasing investments to develop healthcare facilities
    • Higher acceptance of percutaneous devices
  • Market Challenges
    • Dearth of skilled physician and lack of reimbursement

Porter's Five Forces: A Strategic Tool for Navigating the Clot Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clot Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clot Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clot Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clot Management Devices Market

A detailed market share analysis in the Clot Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clot Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clot Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clot Management Devices Market

A strategic analysis of the Clot Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clot Management Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, F. Hoffmann-La Roche AG, GE Healthcare, LeMaitre Vascular, Inc., Medela AG, Medtronic PLC, Merck KGaA, Merit Medical Systems, Inc, Penumbra, Inc, Siemens AG, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Clot Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Catheter-Directed Thrombolysis devices, Embolectomy Balloon Catheters, Inferior Vena Cava Filters, Neurovascular Embolectomy Devices, and Percutaneous Thrombectomy Devices.
  • Based on End-User, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing critical diseases including coronary heart diseases and peripheral arterial diseases
      • 5.1.1.2. Rising elderly population closer to higher risk to diseases development
      • 5.1.1.3. Demand for effective thrombectomy/embolectomy devices
    • 5.1.2. Restraints
      • 5.1.2.1. Conventional method practices in several economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments to develop healthcare facilities
      • 5.1.3.2. Higher acceptance of percutaneous devices
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled physician and lack of reimbursement
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clot Management Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Catheter-Directed Thrombolysis devices
  • 6.3. Embolectomy Balloon Catheters
  • 6.4. Inferior Vena Cava Filters
  • 6.5. Neurovascular Embolectomy Devices
  • 6.6. Percutaneous Thrombectomy Devices

7. Clot Management Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals

8. Americas Clot Management Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Clot Management Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Clot Management Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acandis GmbH
  • 2. AngioDynamics, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Edwards Lifesciences Corporation
  • 6. F. Hoffmann-La Roche AG
  • 7. GE Healthcare
  • 8. LeMaitre Vascular, Inc.
  • 9. Medela AG
  • 10. Medtronic PLC
  • 11. Merck KGaA
  • 12. Merit Medical Systems, Inc
  • 13. Penumbra, Inc
  • 14. Siemens AG
  • 15. Teleflex Incorporated
  • 16. Terumo Corporation